Washington Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2
Closed -$691 446
2025
Q1
$691 Sell
2
-20
-91% -$6.43K ﹤0.01% 751
2024
Q4
$6.6K Sell
22
-180
-89% -$62.9K ﹤0.01% 708
2024
Q3
$82.1K Hold
202
﹤0.01% 380
2024
Q2
$64.9K Hold
202
﹤0.01% 408
2024
Q1
$67.4K Hold
202
﹤0.01% 411
2023
Q4
$54.7K Buy
202
+22
+12% +$5.44K ﹤0.01% 415
2023
Q3
$44.3K Hold
180
﹤0.01% 409
2023
Q2
$54.6K Buy
180
+90
+100% +$25K ﹤0.01% 405
2023
Q1
$23.7K Hold
90
﹤0.01% 537
2022
Q4
$21.6K Buy
+90
New +$20.2K ﹤0.01% 542
2020
Q2
Sell
-100
Closed -$9K 922
2020
Q1
$9K Buy
+100
New +$12.9K ﹤0.01% 685

Other funds holding HCA

Washington Trust's HCA Position: Q2 2025 in Review

Washington Trust sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 2 shares — an estimated $691 sold.

Washington Trust first reported a position in HCA in Q1 2020 and held it in 11 quarters. The position peaked at $82.1K in Q3 2024. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Washington Trust reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 2 HCA Healthcare shares in Q2 2025, an estimated $691.
  • Washington Trust first reported a position in HCA Healthcare in Q1 2020 and held it in 11 quarters.
  • Washington Trust's HCA Healthcare position peaked at $82.1K in Q3 2024.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.